Novo Nordisk A/S logo
Novo Nordisk A/S NVO
€ 34.19 -1.14%

Geschäftsbericht 2025
hinzugefügt 04.04.2026

report update icon

Novo Nordisk A/S Abschreibung & Amortisation 2011-2026 | NVO

Abschreibung & Amortisation Jährlich Novo Nordisk A/S

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - - 6.02 B 5.75 B 5.66 B - - - - - - - -

Alle Zahlen in DKK-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
6.02 B 5.66 B 5.81 B

Abschreibung & Amortisation anderer Aktien in der Pharmaeinzelhändler

Name Abschreibung & Amortisation Preis % 24h Marktkapitalisierung Land
Acorda Therapeutics Acorda Therapeutics
ACOR
31.7 M - -24.86 % $ 820 K usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
3.65 M - - $ 86.2 M usaUSA
Akouos Akouos
AKUS
2.49 M - 0.23 % $ 488 M usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
55.7 M $ 326.56 -2.05 % $ 42.8 B usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
3.13 M - - $ 10.1 M usaUSA
I-Mab I-Mab
IMAB
23.9 M - - $ 866 M chinaChina
AlloVir AlloVir
ALVR
13 K - 4.14 % $ 49.1 M usaUSA
Aligos Therapeutics Aligos Therapeutics
ALGS
930 K $ 7.76 4.51 % $ 76.7 M usaUSA
Allakos Allakos
ALLK
6.14 M - - $ 28.6 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
162 K - - $ 7.46 M israelIsrael
Aptinyx Aptinyx
APTX
122 K - -39.0 % $ 4.57 M usaUSA
Aravive Aravive
ARAV
886 K - -13.39 % $ 1.45 M usaUSA
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
199 K - -2.5 % $ 5.88 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
31.6 M $ 21.48 -0.92 % $ 1 B usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
681 K - - $ 3.45 B usaUSA
Cabaletta Bio Cabaletta Bio
CABA
1.65 M $ 3.45 1.32 % $ 347 M usaUSA
Advaxis Advaxis
ADXS
369 K - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
58 K - 5.93 % $ 314 M canadaCanada
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
24 K $ 3.1 -4.32 % $ 5.1 M israelIsrael
AgeX Therapeutics AgeX Therapeutics
AGE
100 K - -10.17 % $ 12.2 K usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
154 K - -5.16 % $ 5.39 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
744 K - - $ 1.01 B usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
1.27 M $ 1.41 -9.12 % $ 363 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.51 M - - $ 26.5 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
548 K $ 4.16 -1.89 % $ 445 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
700 K $ 24.22 -1.46 % $ 3.08 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
105 K - 1.93 % $ 17.4 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
140 K - -4.8 % $ 255 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
8.3 M $ 1.48 -0.67 % $ 394 M britainBritain
Aptose Biosciences Aptose Biosciences
APTO
22 K - -45.71 % $ 1.2 M canadaCanada
BeiGene, Ltd. BeiGene, Ltd.
BGNE
142 M - 0.49 % $ 251 B cayman-islandsCayman-islands
Caladrius Biosciences Caladrius Biosciences
CLBS
174 K - -16.75 % $ 25.8 M usaUSA
AVROBIO AVROBIO
AVRO
617 K - 1083.1 % $ 745 M usaUSA
Clearside Biomedical Clearside Biomedical
CLSD
67 K - - $ 25.3 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
3.38 M $ 33.53 -1.0 % $ 2.23 B usaUSA
bluebird bio bluebird bio
BLUE
28 M - - $ 546 M usaUSA
CNS Pharmaceuticals CNS Pharmaceuticals
CNSP
3.92 K $ 2.66 -3.34 % $ 1.18 M usaUSA